A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of, or reimbursement for, drugs manufactured in China, and for other purposes.
About This Bill
Committee
Latest Action · May 6, 2020
Read twice and referred to the Committee on Finance.